FEMY — FEMASYS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1339005 ·
Last close
$2.00
Market Cap
$16.75M
52W High
$22.20
52W Low
$1.94
ADV30
106,635
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 331,827 | 189,391 | -5,065,874 | -4,469,095 | 12,289,582 | 1,443,502 | 8,258,635 |
| Mar 2026 | 424,889 | 266,283 | -4,223,533 | 846,100 | 16,495,245 | 5,386,041 | 9,205,352 |
| Dec 2025 | 813,387 | 510,262 | -4,622,728 | -3,950,305 | 20,724,177 | 9,266,353 | 14,854,875 |
| Sep 2025 | 729,394 | 435,556 | -3,653,768 | -4,194,821 | 16,290,153 | 4,569,038 | 11,733,902 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,068,859
Investing CF
$-612,631
Financing CF
$20,247,323
CapEx
$-612,631
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-9.80
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-144,980,044
Inventory
$6,105,267
Receivables
$172,264
ST Investments
—
EBIT TTM
$-10,271,186
Pretax Income TTM
$-11,879,463
Interest Exp TTM
$1,608,277
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,299,497
EBITDA
$-17,229,926
Free Cash Flow
$-11,230,021
Enterprise Value
$26,629,318
Total Cash
$1,443,502
Total Debt
$4,790,245
Shares Out
8,375,027
Trailing EPS
$-2.72
Book Value
$1.33
ROE
-425.0%
ROA
-84.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,293,313 | -17,588,669 | -18,627,887 | 20,724,177 | 14,854,875 | 5,869,302 | -18,690,565 |
| Dec 2024 | 1,629,108 | -17,785,805 | -18,816,628 | 12,445,002 | 10,140,580 | 2,304,422 | -19,444,009 |
| Dec 2023 | 1,071,970 | -14,508,415 | -14,247,124 | 27,755,825 | 9,403,236 | 18,352,589 | -11,280,546 |
| Dec 2022 | 1,206,218 | -11,600,264 | -11,394,170 | 16,895,570 | 1,653,051 | 15,242,519 | -10,731,973 |
TTM Snapshot
Revenues TTM
$2,376,938
NetIncome TTM
$-11,884,948
OpCashFlow TTM
—
Assets (Latest)
$16,495,245
Forward EPS
$-2.12
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HCIL | Hongchang International Co., Ltd | $17.38M | $0.03 | — |
| ICU | SeaStar Medical Holding Corp | $15.91M | $3.61 | — |
| IRIX | IRIDEX CORP | $15.63M | $0.89 | — |
| LFWD | Lifeward Ltd. | $18.38M | $6.49 | — |
| CNSY | CERENOME, INC. | $14.65M | $1.93 | — |
News headlines (Yahoo Finance, 1h cache)
Femasys to Showcase FemaSeed Fertility Treatment at ASRM 2026 as Commercialization Strategy Expands
2026-10-08 14:38 · Yahoo
Femasys to Exhibit at the ASRM 2026 Scientific Congress & Expo
2026-10-08 13:00 · Yahoo
Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care
2026-09-15 13:00 · Yahoo
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
2026-08-26 13:00 · Yahoo
Femasys Secures FDA Pathway for Non-Surgical Contraceptive
2026-08-19 17:36 · Yahoo
FEMY Stock Rallies On Key Regulatory Milestone For Investigational Birth Control Technology – Retail Sees 500% Upside Potential
2026-08-19 16:01 · Yahoo
Femasys Secures FDA Approval for Modular PMA Pathway for FemBloc
2026-08-19 14:37 · Yahoo
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
2026-08-19 13:00 · Yahoo
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
2026-08-12 13:00 · Yahoo
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
2026-08-07 13:25 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.